The roles of telomeres and telomerase in cellular immortalization and the development of cancer

Anticancer Research

Volumn 19, Issue 6 A, 1999, Pages 4823-4830

  Klingelhutz, Aloysius J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

hTERT; Immortalization; Senescence; Telomerase; Telomeres

Indexed keywords

TELOMERASE;

CANCER THERAPY; CARCINOGENESIS; CELL CULTURE; CELL IMMORTALIZATION; CELL SURVIVAL; HUMAN; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TELOMERE;

CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0033368122     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exptl Cell Res 25: 585-621, 1961.
2. Shay JW, Wright WE and Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072: 1-7, 1991.
3. Orgel LE: The maintenance of the accuracy of protein synthesis and its relevance to ageing. Proc Natl Acad Sci USA 49: 517-521, 1963.
4. Ohno S and Nagai Y: Genes in multiple copies as the primary cause of aging. Birth Defects Orig Articles Ser 14: 501-514, 1978.
5. Kirkwood TB and Holliday R: Commitment to senescence: a model for the finite and infinite growth of diploid and transformed human fibroblasts in culture. J Theor Biol 53: 481-496, 1975.
6. Smith JR and Lumpkin CK: Loss of gene repression activity: a theory of cellular senescence. Mech Ageing Dev 13: 387-392, 1980.
7. Pereira-Smith OM and Smith JR: Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 85: 6042-6046, 1988.
8. Harley CB, Vaziri H, Counter CM and Allsopp RC: The telomere hypothesis of cellular aging. Exp Gerontol 27: 375-382, 1992.
9. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991.
10. Olovnikov AM: Principles of marginotomy in template synthesis of polynucleotides. Dokl Acad Nauk (S S S R ) 201: 1496-1499, 1971.
11. Olovnikov AM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41: 181-190, 1973.
12. Levy MZ, Allsopp RC, Futcher AB, Greider CW and Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 225: 951-960, 1992.
13. Blackburn EH: Telomeres. [Review]. Trends Biochem Sci 16: 378-381, 1991.
14. Greider CW: Telomeres. [Review]. Curr Opin Cell Biol 3: 444-451, 1991.
15. Zakian VA: Structure and function of telomeres. Annu Rev Genet 23: 579-604, 1989.
16. Moyzis RK, Buckingham JM, Cram LS et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
17. Muller HJ: The remaking of chromosomes. The Collecting Net-Woods Hole 13: 181-198, 1938.
18. McClintock B: The stability of broken ends of chromosomes in Zea mays. Genetics 41: 234-282, 1941.
19. Wright WE and Shay JW: Telomere positional effects and the regulation of cellular senescence. Trends Genet 8: 193-197, 1992.
20. Aparicio OM, Billington BL and Gottschling DE: Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae. Cell 66: 1279-1287, 1991.
21. Gottschling DE, Aparicio OM, Billington BL and Zakian VA: Position effect at S. Cerevisiae telomeres: reversible repression of Pol II transcription. Cell 63: 751-762, 1990.
22. Henikoff S: Position-effect variegation after 60 years. Trends Genet 6: 422-426, 1990.
23. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
24. Greider CW and Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51: 887-898, 1987.
25. Greider CW: Telomerase is processive. Mol Cell Biol 11: 4572-4580, 1991.
26. Greider W and Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337, 1989.
27. McEachern MJ and Blackburn EH: Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376: 403-409, 1995.
28. Guo-Liang Y, Bradley JD, Attardi LD and Blackburn EH: In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126-132, 1990.
29. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
30. Kim NW, Piatyszek MA, Prowse KR et al: Specific association of human telomerase activity with immortal cells and cancer: Science 266: 2011-2015, 1994.
31. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
32. Allsopp RC, Chang E, Kashefiaazam M et al: Telomere shortening is associated with cell division in vitro and in vivo. Exptl Cell Res 220: 194-200, 1995.
33. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
34. Counter CM, Avilion AA, LeFeuvre CE et al: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
35. Counter CM, Botelho FM, Wang P, Harley CB and Bacchetti S: Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 68: 3410-3414, 1994.
36. Klingelhutz AJ, Barber SA, Smith PP, Dyer K and McDougall JK: Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 14: 961-969, 1994.
37. Feng JL, Funk WD, Wang SS et al: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
38. Kirk KE, Harmon BP, Reichardt IK, Sedat JW and Blackburn EH: Block in anaphase chromosome separation caused by a telomerase template mutation. Science 275: 1478-1481, 1997.
39. Marusic L, Anton M, Tidy A, Wang P, Villeponteau B and Bacchetti S: Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomercs that correlate with reduced cell viability. Mol Cell Biol 17: 6394-6401, 1997.
40. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Grcider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650, 1996.
41. Soder AI, Hoare SF, Muir S, Going JE, Parkinson EK and Keith WN: Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14: 1013-1021, 1997.
42. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V and Cech TR: Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561-567, 1997.
43. Kilian A, Bowtell DDL, Abud HE et al: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019, 1997.
44. Nakamura TM, Morin GB, Chapman KB et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
45. Meyerson M, Counter CM, Eaton EN et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
46. Nakano K, Watney E and McDougall JK: Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Amer J Pathol In Press: 1998.
47. Beattie TL, Zhou W, Robinson MO, and Harrington L: Reconstitution of human telomerase activity in vitro. Curr Biol 8: 177-180, 1997.
48. Weinrich SL, Pruzan R, Ma L et al: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Gen 17: 498-502, 1997.
49. Nakayama J, Tahara H, Tahara E et al: Telomerase activation hy hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Gen 18: 65-68, 1998.
50. Counter CM, Meyerson M, Eaton EN et al: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222, 1998.
51. Bodnar AG, Ouellette M, Frolkis M et al: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
52. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ: Telomerase activity and inactivation of Rh/p16INK4a are required for immortalization of epithelial cells. Nature In Press: 1998.
53. van Steensel B and de Lange T: Control of telomere length by the human telomeric protein TRF-1. Nature 385: 740-743, 1997.
54. van Steensel B, Smogorzewska A and de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413, 1998.
55. Holt SE, Wright WE, and Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932-2939, 1996.
56. Harle-Bachor C and Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481, 1996.
57. Yasumoto S, Kunimura C, Kikuchi K et al: Telomerase activity in normal human epithelial cells. Oncogene 13: 433-439, 1996.
58. Counter CM, Gupta J, Harley CB, Leber B, and Bacchelti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
59. Broccoli D, Young JW and de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
60. Igarashi H and Sakaguchi N: Telomerase activity is induced by the stimulation of antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Comm 219: 649-655, 1996.
61. Hiyama K, Hirai Y, Kyoizumi S et al: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
62. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW: Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106: 759-765, 1996.
63. Belair CD, Yeager TR, Lopez PM, and Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682, 1997.
64. Fujimoto K and Takahashi M: Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxy-nucleotides targeted against c-myc mRNA. Biochem Biophys Res Comm 241: 775-781, 1997.
65. Wang J, Xie LY, Allan S, Beach D, and Hannon GJ: Myc activates telomerase. Genes Devel 12: 1769-1774, 1998.
66. Mandal M and Kumar R: Bcl-2 modulates telomerase activity. J Biol Chem 272: 14183-14187, 1997.
67. Klingelhutz AJ, Foster SA and McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82, 1996.
68. Holt SE, Aisner DL, Shay JW and Wright WE: Lack of cell cycle regulation of telomerase activity in human cells, Proc Natl Acad Sci US 94: 10687-10692, 1997.
69. Sharma HW, Sokoloski JA, Perez JR et al: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92: 12343-12346, 1995.
70. Xu D, Gruber A, Peterson C et al: Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 10: 1354-1357, 1996.
71. Xu HJ, Zhou Y, Ji W et al: Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15: 2589-2596, 1997.
72. Shay JW and Wright WE: Telomerase activity in human cancer. Curr Opin Oncol 8: 66-71, 1996.
73. Chadeneau C, Hay K, Hirtc HW, Gallinger S and Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
74. Hiyama E, Gollahon L, Kataoka T et al: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
75. Kyo S, Takakura M, Ishikawa H et al: Application of telomerase assay for the screening of cervical lesions. Cancer Res 57: 1863-1867, 1997.
76. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995.
77. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G and Wallwiener D: Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Inter J Cancer 79: 8-12, 1998.
78. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, and Toyama K: Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 11: 190-194, 1997.
79. Norton JC, Holt SE, Wright WE and Shay JW: Enhanced detection of human telomerase activity. DNA Cell Biol 17: 217-219, 1998.
80. Krupp G, Kuhne K, Tamm T et al: Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucl Acids Res 25: 919-921, 1997.
81. Wright WE, Shay JW and Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increase reliability, linearity and sensitivity. Nucl Acids Res 23: 3794-3795, 1995.
82. Falchetti ML, Levi A, Molinari P, Verna R and Dambrosio E: Increased sensitivity and reproducibility of TRAP assay by avoiding direct primer interaction. Nucl Acids Res 26: 862-863, 1998.
83. Kim NW and Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucl Acids Res 25: 2595-2597, 1997.
84. Kavaler E, Landman J, Chang YL, Droller MJ and Liu BCS: Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 82: 708-714, 1998.
85. Villa R, Zaffaroni N, Folini M et al: Telomerase activity in benign and malignant breast lesions-A pilot prospective study on fine-needle aspirates. J Natl Cancer Inst 90: 537-539, 1998.
86. Ogoshi M, Le T, Shay JW and Taylor RS: In Situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 110: 818-823, 1998.
87. Bryan TM, Englezou A, Gupta J, Bacchetti S and Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.
88. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomerc length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997.
89. Blasco MA, Funk W, Villeponteau B and Greider CW: Functional characterization and developmental regulation of mouse telomerase RNA. Science 269: 1267-1270, 1995.
90. Blasco MA, Rizen M, Greider CW and Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Gen 12: 200-204, 1996.
91. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW and DePinho RA: Essential role of mouse telomerase in highly proliterative organs. Nature 392: 569-574, 1998.
92. Norton JC, Piatyszek MA, Wright WE, Shay JW and Corey DR: Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotech 14: 615-619, 1996.
93. Ku WC, Cheng AJ and Wang TCV: Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Comm 241: 730-736, 1997.
94. Sun DY, Thompson B, Cathers BE et al: Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 40: 2113-2116, 1997.
95. Kanazawa Y, Ohkawa K, Ueda K et al: Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem Biophys Res Comm 225: 570-576, 1996.
96. Strahl C and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65, 1996.
97. Kyo S, Takakura M, Kohama T and Inoue M: Telomerase activity in human endometrium. Cancer Res 57: 610-614, 1997.
98. Klingelhutz AJ: Telomerase activation and cancer. J Mol Med 75: 45-49, 1997.
99. Harrington L, Mcphail T, Mar V et al: A mammalian telomerase-associated protein. Science 275: 973-977, 1997.